Your home for biotech and planetary health insight and opinion.
Let's build rapport.
China is the reason why the US’s MFN experiment will be short lived
China is well positioned to fill the biotech innovation gaps in the global economy that the US leaves behind. America’s “most-favored nation” drug pricing policies will present China with the opportunity to serve the world’s need for innovative medicines if the US continues to isolate itself.
*Keep me informed! I understand I’m opting into letting the RA Capital team contact me, which is totally fine cause they aren’t boring.
about
RApport is an online communications hub for members of the biotech and planetary health communities to share their ideas, problems, and solutions. Founded and run by employees of RA Capital, RApport is a place to gather insight and opinions from across these industries.
We encourage you to share your thoughts with us on Twitter @RApport_Bio.